Tirzepatide
A novel dual GIP and GLP-1 receptor agonist with a 39-amino-acid backbone and a C20 fatty diacid moiety for albumin binding, giving a half-life of about 5 days.
A comprehensive database of research-grade peptides, each with detailed study notes, molecular data and certificate-of-analysis specifications.
A novel dual GIP and GLP-1 receptor agonist with a 39-amino-acid backbone and a C20 fatty diacid moiety for albumin binding, giving a half-life of about 5 days.
A long-acting GLP-1 receptor agonist with a 31-amino-acid backbone and a lipophilic side chain that extends its half-life to roughly one week.
A triple agonist peptide targeting the GLP-1, GIP and glucagon receptors simultaneously. Currently in Phase 3 clinical trials.
A synthetic pentadecapeptide derived from a gastric juice protein, widely studied for its reported cytoprotective and tissue-repair activity.
A synthetic version of thymosin beta-4, studied for its role in actin regulation and its reported effects on cell migration and repair.
A selective growth-hormone secretagogue pentapeptide, studied for its selectivity and minimal effect on cortisol and prolactin.
A long-acting growth-hormone-releasing hormone analogue bearing a Drug Affinity Complex that extends its half-life considerably.
A naturally occurring copper-binding tripeptide studied for its role in collagen synthesis, antioxidant activity and skin remodelling.
A synthetic ACTH(4-10) analogue studied for its reported effects on cognition, attention and neuroprotection.
A mitochondria-targeted tetrapeptide that selectively associates with cardiolipin and is studied for its effects on mitochondrial bioenergetics.
A cyclic melanocortin receptor agonist studied for its central effects on sexual desire via the MC4 receptor pathway.
You need to login to view this feature
This address will be removed from this list
Fraudsters are impersonating our brand. Before making any transaction, please verify through our official website that the person you are talking to is genuinely one of our team. Be alert to fake accounts and report suspicious activity.